Clorox has seen its share price slide over recent years, which naturally pushes investors to ask whether the current US$83.80 level is still aligned with what the business earns. With the focus squarely on earnings power rather than headlines, the question is how well the stock price and the profit stream match up today.
- Over the past 5 years, the share price has fallen 39.3%, which puts the spotlight on whether the earnings profile can still support the current valuation.
- The business relies on branded household products that tend to generate steady revenue and cash flow, which can support an earnings based valuation even when sentiment around the stock is weak.
- There is a second opinion on Clorox worth weighing. See what analysts think Clorox’s shares could be worth.
The issue now is whether Clorox’s present share price is justified by its earnings when set against a Fair Ratio benchmark.
To compare how fairly Clorox is being priced on its earnings against other opportunities, you can run the same test across a wider list of 32 high quality undervalued stocks
Is Clorox Still Cheap on Earnings?
The P/E ratio fits Clorox because investors usually judge mature, branded consumer businesses on the cash they can earn per share. On this yardstick, Clorox trades on about 17.3x earnings, which is lower than both the Household Products industry average of roughly 16.1x and the broader peer group around 19.6x, so the stock does not screen as aggressively priced on headline earnings.
A more tailored benchmark is the Fair Ratio, which reflects what P/E you might expect given Clorox’s size, margins and risk profile. The present 17.3x multiple sits below that Fair Ratio, which points to the shares changing hands at a discount to what this framework suggests could be justified by the business fundamentals. Explore the numbers behind Clorox’s P/E valuation.
The Clorox Narrative: What Would Justify Today’s Price?
Simply Wall St Narratives for Clorox pick up where the valuation puzzle leaves off and spell out what combination of future growth, margins and earnings would need to play out for the stock to be worth materially more or less than today’s price. Instead of a single ratio or model output, they map the business assumptions sitting underneath that number so you can track over time whether Clorox’s actual progress keeps matching the story implied by the valuation.
Clorox currently attracts two very different readings, with one side focused on an earnings rebuild and the other on rising execution and category risks.
Bull case: 17% undervalued
“Expansion of health and hygiene as Clorox’s main focus, including the GOJO and Clorox Healthcare platforms that now represent over half of company sales…”
Discover why this Narrative puts Clorox at 17% undervalued.
Bear case: 9% overvalued
“Intensifying consumer shift toward sustainable and zero-waste lifestyles, along with growing skepticism about chemical-based cleaning products, threatens to erode Clorox’s core category revenues…”
Explore why this Narrative puts Clorox at 9% overvalued.
Before acting on Clorox’s valuation, there is one more piece to examine
The people setting Clorox’s priorities, and how their paychecks line up with long term owners, can tilt the whole investment case. That alignment puzzle has not been unpacked here yet. See who runs Clorox and how they are paid.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
